Non-invasive prenatal testing is regularly used to screen for aneuploidies and Rhesus status of a fetus. Since 1997 when free fetal DNA (ffDNA) in the maternal circulation was first identified, it has been hypothesized that may be possible use non-invasive (NIPT) identify high-risk pregnancies including pre-eclampsia, growth restriction preterm birth. then there much interest this area as way u...